RYBELSUS is a glucagon-like pept ide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes m ellitus (1)
Both believe in RYBELSUS ® as an option to lower blood glucose for appropriate adult patients with T2D
The most common side effects with Rybelsus (which may affect more than 1 in 10 people) are nausea (feeling sick), diarrhoea and low blood sugar levels (when used with insulin
Important Safety Information | Patient Site RYBELSUS® (semaglutide) dosing guide and schedule Important information for properly prescribing RYBELSUS ®
What is in this leaflet
Learn about side effects, how to take, uses, and more of Rybelsus (semaglutide)
RYBELSUS tablets, for oral use, contain semaglutide, a GLP-1 receptor agonist
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion
What you need to know before you take Rybelsus® 3
a To receive offer, 7 mg or 14 mg dose prescription must be for a 1-, 2-, or 3-month supply
Se desconoce si RYBELSUS ® se puede usar en personas que han tenido pancreatitis
Last updated on emc: 19 Jan 2024
Each tablet contains 3 mg semaglutide*
*human glucagon-like peptide-1 (GLP-1) analogue produced in Saccharomyces cerevisiaecells by recombinant DNA technology
3 DOSAGE FORMS AND STRENGTHS RYBELSUS ® tablets are available as: • 3 mg: white to light yellow, oval shaped debossed with “3” on one side and “novo” on the other side
You can also report side effects directly via the Yellow Card Scheme at By reporting side effects you can help to provide more Please see the Package Leaflet for more information or contact your doctor or nurse with any questions about how to manage your type 2 diabetes or use RYBELSUS ®
Prezentare produs: CUTIE CU BLIST AL/AL x90 COMPR
Swallow tablets whole
Do not use a pill organizer or other container to store RYBELSUS® tablets
g
Maximum savings of $300 per 1‑month supply, $600 per 2‑month supply, or $900 per 3‑month supply
Rybelsus is an oral tablet which is taken once a day
Limitations of Use • RYBELSUS® has not been studied in patients with a history of pancreatitis
After 30 days on the 3 mg dosage, increase the dosage to 7 mg once daily